【摘要】：目的探討1 470nm半導(dǎo)體激光治療淺表性膀胱腫瘤的臨床療效。方法將2012年1月至2014年1月收治的淺表性膀胱腫瘤患者216例,分為激光組和電切組,分別行1 470nm半導(dǎo)體激光和等離子電切術(shù)治療,比較兩組患者的療效。結(jié)果激光組的手術(shù)時(shí)間、術(shù)中出血量、留置尿管時(shí)間及術(shù)后住院時(shí)間均明顯小于電切組,且激光組術(shù)中和術(shù)后6h的血腎上腺素、去甲腎上腺素及血管緊張素Ⅱ水平均明顯低于電切組(P0.05)。激光組未發(fā)生閉孔神經(jīng)反射和膀胱穿孔,總并發(fā)癥發(fā)生率為5.1%,術(shù)后24個(gè)月膀胱腫瘤復(fù)發(fā)率為7.1%;電切組閉孔神經(jīng)反射發(fā)生率為7.6%,膀胱穿孔發(fā)生率為1.7%,總并發(fā)癥發(fā)生率為15.3%,術(shù)后24個(gè)月膀胱腫瘤復(fù)發(fā)率為17.8%;激光組的上述指標(biāo)均明顯低于電切組(P0.05)。結(jié)論 1 470nm半導(dǎo)體激光手術(shù)治療非浸潤(rùn)性膀胱腫瘤臨床療效確切,操作簡(jiǎn)單,術(shù)后并發(fā)癥發(fā)生率低,安全性高,中遠(yuǎn)期復(fù)發(fā)率低,且對(duì)患者應(yīng)激水平影響小。
[Abstract]:Objective to investigate the clinical efficacy of 1 470nm semiconductor laser in the treatment of superficial bladder tumor. Methods two hundred and sixteen patients with superficial bladder tumor from January 2012 to January 2014 were divided into two groups: laser group and electrosurgical group. 1 470nm semiconductor laser and plasma resection were performed respectively. The curative effects of the two groups were compared. Results the time of operation, the amount of bleeding, the time of indwelling catheter and the time of hospitalization in the laser group were significantly shorter than those in the electrosurgical group, and the blood adrenaline in the laser group was significantly lower than that in the laser group during operation and 6 hours after operation. Norepinephrine and angiotensin 鈪，

本文編號(hào)：2431725